Citius Oncology Inc
NASDAQ:CTOR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Citius Oncology Inc
NASDAQ:CTOR
|
US |
|
Spirit Technology Solutions Ltd
ASX:ITS
|
AU |
|
Cambridge Cognition Holdings PLC
LSE:COG
|
UK |
|
Rosseti Lenenergo PAO
MOEX:LSNG
|
RU |
|
C
|
Cantor Equity Partners VI Inc
NASDAQ:CEPS
|
US |
Wall St Price Targets
CTOR Price Targets Summary
Citius Oncology Inc
According to Wall Street analysts, the average 1-year price target for CTOR is 4.08 USD with a low forecast of 4.04 USD and a high forecast of 4.2 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CTOR's stock price target?
Price Target
4.08
USD
According to Wall Street analysts, the average 1-year price target for CTOR is 4.08 USD with a low forecast of 4.04 USD and a high forecast of 4.2 USD.